Target keeps pace with Wal-Mart on drug discounts FDA issues approvable letter for Surfaxin NACDS Foundation announces election results Young joins Perrigo as pharmacovigilance manager Pfizer initiates settlements of its painkiller cases Study suggests increased compliance from lowered co-pays FDA to review Purdue's attempt at tamper-resistant OxyContin My Documents' passports allow patients to monitor their medical records Wal-Mart’s $4 generic program expanded again FDA names board of CTTI First Previous 2509 2510 2511 2512 2513 Next Last
